by Advize Admin | Jul 8, 2022 | COVID19, Healthcare
The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect tens of thousands of people and kill hundreds each day. Its success in...
by Erik Consorsha | Jul 30, 2021 | Healthcare
Three years ago, pharma giant Pfizer paid $24 million to settle federal allegations that it was paying kickbacks and inflating sales by reimbursing Medicare patients for out-of-pocket medication costs. By making prohibitively expensive medicine essentially...
Recent Comments